Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.20    -0.40 (-0.20%)
Bid:
201.20
Ask:
203.00
Spread: 1.80 (0.895%)
Market Cap: £1.31b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Q2 AuM Statement

14 Jan 2014 07:00

RNS Number : 5534X
Ashmore Group PLC
14 January 2014
 



Ashmore Group plc

+0700 14 January, 2014

SECOND QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist emerging markets asset manager, announces today the following update to its assets under management ("AuM") in respect of the quarter ended 31 December 2013.

Assets under Management

Theme

Actual30 September 2013

(US$ billion)

Estimated31 December 2013

(US$ billion)

Movement

Q2 vs Q1(%)

External debt

13.8

13.4

-2.9

Local currency

17.2

16.9

-1.7

Corporate debt

6.4

7.0

+9.4

Blended debt

19.7

19.1

-3.0

Equities

5.7

5.3

-7.0

Alternatives

2.9

2.5

-13.8

Multi-strategy

3.3

2.8

-15.2

Overlay / liquidity

9.5

8.3

-12.6

Total

78.5

75.3

-4.1

 

Assets under management declined during the quarter to US$75.3 billion as a result of net outflows totalling US$3.5 billion and positive investment performance of US$0.3 billion.

The majority of the net outflow resulted from a small number of redemptions from segregated mandates in the blended debt and overlay / liquidity themes. The external debt, equities and multi-strategy themes also experienced net outflows, and alternatives funds returned capital as expected during the quarter. Corporate debt saw a net inflow.

There were modest positive contributions to investment performance in equities, external debt, corporate debt, and blended debt, offset by mildly negative performance in local currency, alternatives and overlay/liquidity.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Market performance and, to some extent, investor behaviour during the quarter continued to be influenced by uncertainty surrounding US monetary policy and the heightened market volatility experienced since early May last year. There is now greater clarity over US monetary policy, and Emerging Market assets offer attractive prospective returns across both equities and fixed income, and especially against Developed Market assets. This continues to give us confidence for the year ahead."

During the quarter, the basis of calculation for the annual investment management fee on two of the Group's closed end special situations funds was amended from 2% of acquisition cost to the lower of 2% of acquisition cost and 2% of net asset value. The amended management fee arrangements applied from 1 October 2013, and the pro forma annualised effect is to reduce revenues from the alternatives theme by US$25 million.

For the translation of US dollar-denominated balance sheet items, the GBP/USD exchange rate was 1.6557 at 31 December 2013, a 9% appreciation since 30 June 2013 (1.5213). For the translation of US dollar management fees, the average GBP/USD exchange rate achieved for the first half of the year was 1.5868 (H1 2012/13: 1.5974).

Ashmore will announce its interim results in respect of the six months ended 31 December 2013 on 25 February 2014.

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI Consulting - PR to Ashmore Group plcAndrew Walton +44 (0)20 7269 7204Paul Marriott +44 (0)20 7269 7252

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFWFADFLSEEF
Date   Source Headline
8th Nov 20224:20 pmRNSHolding(s) in Company
28th Oct 202210:13 amRNSHolding(s) in Company
14th Oct 20222:11 pmRNSResult of AGM
14th Oct 20227:00 amRNSTrading Statement
5th Oct 20226:03 pmRNSHolding(s) in Company
23rd Sep 20224:56 pmRNSDirector/PDMR Shareholding
15th Sep 202210:36 amRNSDirector/PDMR Shareholding
14th Sep 20226:00 pmRNSHolding(s) in Company
9th Sep 20225:19 pmRNSNotice of AGM
2nd Sep 20227:00 amRNSFinal Results
22nd Jul 202211:33 amRNSDirectorate Change
14th Jul 20227:00 amRNSTrading Statement
25th Apr 20227:00 amRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Statement
1st Apr 20223:02 pmRNSDirector/PDMR Shareholding
21st Mar 20224:30 pmRNSDirectorate Change
17th Mar 202211:35 amRNSDirector/PDMR Shareholding
17th Jan 20227:00 amRNSTrading Statement
13th Dec 202111:34 amRNSDirector/PDMR Shareholding
15th Oct 20213:42 pmRNSResult of AGM
14th Oct 20217:00 amRNSTrading Statement
23rd Sep 202112:27 pmRNSDirector/PDMR Shareholding
23rd Sep 202112:24 pmRNSDirector/PDMR Shareholding
17th Sep 20219:52 amRNSDirector/PDMR Shareholding
17th Sep 20219:48 amRNSDirector/PDMR Shareholding
10th Sep 20214:00 pmRNSNotice of AGM
3rd Sep 20217:00 amRNSFinal Results
14th Jul 20217:00 amRNSTrading Statement
30th Apr 20212:51 pmRNSDirector/PDMR Shareholding
23rd Apr 20213:12 pmRNSDirectorate Change
16th Apr 20217:00 amRNSTrading Statement
13th Apr 20213:45 pmRNSAGM voting result update statement
6th Apr 20212:54 pmRNSDirector/PDMR Shareholding
6th Apr 20212:37 pmRNSDirector/PDMR Shareholding
18th Mar 20216:02 pmRNSDirector/PDMR Shareholding
16th Feb 20214:35 pmRNSHolding(s) in Company
16th Feb 20214:29 pmRNSDirector/PDMR Shareholding
10th Feb 20217:00 amRNSHalf-year Report
15th Jan 20217:00 amRNSTrading Statement
11th Dec 20205:40 pmRNSDirector/PDMR Shareholding
11th Dec 20205:37 pmRNSDirector/PDMR Shareholding
19th Oct 20206:20 pmRNSHolding(s) in Company
19th Oct 20205:47 pmRNSDirector/PDMR Shareholding
16th Oct 20204:14 pmRNSResult of AGM
14th Oct 20207:00 amRNSTrading Statement
7th Oct 20209:42 amRNSHolding(s) in Company
25th Sep 20202:20 pmRNSAGM arrangements
22nd Sep 20206:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20206:03 pmRNSDirector/PDMR Shareholding
22nd Sep 20208:26 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.